Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes

Hepatocellular carcinoma (HCC) is a highly aggressive and lethal cancer. It is typically asymptomatic at the early stage, with only 10%–20% of HCC patients being diagnosed early enough for appropriate surgical treatment. The delayed diagnosis of HCC is associated with limited treatment options and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ping, Yang, Xiaoyang, Qi, Shibo, Liu, Hongguang, Jiang, Han, Hoppmann, Susan, Cao, Qizhen, Chua, Mei-Sze, So, Samuel K., Cheng, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654646/
https://www.ncbi.nlm.nih.gov/pubmed/23710458
http://dx.doi.org/10.1155/2013/759057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654646/
https://www.ncbi.nlm.nih.gov/pubmed/23710458
http://dx.doi.org/10.1155/2013/759057

Ejemplares similares